XML 69 R52.htm IDEA: XBRL DOCUMENT v2.4.0.8
Loan Payable - Additional Information (Detail) (USD $)
9 Months Ended 1 Months Ended 9 Months Ended 1 Months Ended
Sep. 30, 2013
Jul. 31, 2013
CIRM Loan Agreement [Member]
Apr. 30, 2013
CIRM Loan Agreement [Member]
Sep. 30, 2012
CIRM Loan Agreement [Member]
Sep. 30, 2013
CIRM Loan Agreement [Member]
Sep. 30, 2013
Silicon Valley Bank Loan Agreement Warrant [Member]
Sep. 30, 2013
Silicon Valley Bank Loan Agreement Warrant [Member]
Common Stock [Member]
Apr. 30, 2013
Silicon Valley Bank [Member]
Debt Instrument [Line Items]                
Proceeds from loan               $ 9,900,000
Loan term 3 years     10 years        
Annual interest rate on loan 6.00%              
Period of loan subject to interest payments only 6 months              
Period of loan subject to principal and interest payments 30 months              
Final fee payment at the end of loan term 1,000,000              
Term of warrants expiration           10 years    
Number of shares of common stock acquired using warrants             293,531  
Exercise price of warrants           1.7034    
Warrants expiration period           April 2023    
Proceeds received under loan agreement 9,900,000              
Initial carrying amount assigned to loan, net of discount 9,512,000              
Fair value allocated to warrant 388,000              
Cash discount 100,000              
Note issuance costs 117,000              
Deferred financing costs, discount and accretion percentage 9.00%              
Approval of fund by California Institute for Regenerative Medicine (CIRM)     19,300,000          
Approval of fund by California Institute for Regenerative Medicine (CIRM) maximum period       4 years        
Loan interest rate description         one year LIBOR rate plus two percent      
LIBOR rate plus percentage         2.00%      
LIBOR rate plus percentage increase         1.00%      
Proceeds from initial disbursement of the loan   $ 3,800,000